RL in patients with multiple myeloma treated with auto/RIC allo or auto alone. RL was lower with auto/RICallo: 52% vs 77% at 60 months and 60% vs 82% at 96 months in the auto/RICallo and auto groups, respectively (overall P = .0002) All patients included—ITT. Gray = auto/RICallo; black = auto.